1. Home
  2. OCFC vs IOVA Comparison

OCFC vs IOVA Comparison

Compare OCFC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCFC
  • IOVA
  • Stock Information
  • Founded
  • OCFC 1902
  • IOVA 2007
  • Country
  • OCFC United States
  • IOVA United States
  • Employees
  • OCFC N/A
  • IOVA N/A
  • Industry
  • OCFC Major Banks
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OCFC Finance
  • IOVA Health Care
  • Exchange
  • OCFC Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • OCFC 861.7M
  • IOVA 1.0B
  • IPO Year
  • OCFC 1996
  • IOVA N/A
  • Fundamental
  • Price
  • OCFC $17.55
  • IOVA $1.66
  • Analyst Decision
  • OCFC Buy
  • IOVA Buy
  • Analyst Count
  • OCFC 4
  • IOVA 10
  • Target Price
  • OCFC $21.25
  • IOVA $12.22
  • AVG Volume (30 Days)
  • OCFC 269.7K
  • IOVA 18.1M
  • Earning Date
  • OCFC 04-24-2025
  • IOVA 05-08-2025
  • Dividend Yield
  • OCFC 4.51%
  • IOVA N/A
  • EPS Growth
  • OCFC N/A
  • IOVA N/A
  • EPS
  • OCFC 1.53
  • IOVA N/A
  • Revenue
  • OCFC $369,879,000.00
  • IOVA $212,679,000.00
  • Revenue This Year
  • OCFC $0.75
  • IOVA $83.64
  • Revenue Next Year
  • OCFC $12.16
  • IOVA $70.34
  • P/E Ratio
  • OCFC $11.59
  • IOVA N/A
  • Revenue Growth
  • OCFC N/A
  • IOVA 11070.12
  • 52 Week Low
  • OCFC $14.03
  • IOVA $2.70
  • 52 Week High
  • OCFC $21.87
  • IOVA $13.60
  • Technical
  • Relative Strength Index (RSI)
  • OCFC 61.06
  • IOVA 26.47
  • Support Level
  • OCFC $17.16
  • IOVA $1.65
  • Resistance Level
  • OCFC $17.99
  • IOVA $2.04
  • Average True Range (ATR)
  • OCFC 0.41
  • IOVA 0.22
  • MACD
  • OCFC 0.13
  • IOVA -0.16
  • Stochastic Oscillator
  • OCFC 75.69
  • IOVA 0.96

About OCFC OceanFirst Financial Corp.

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: